Investigating the effectiveness of the digital lifestyle intervention actensio to reduce blood pressure in adults with hypertension after six months of use
- Conditions
- I10Essential (primary) hypertension
- Registration Number
- DRKS00032452
- Lead Sponsor
- mementor DE GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 422
Consent to participate in the clinical trial
- Age over 18 years
- Diagnosis of essential hypertension (practice SBP 140-179 mmHg and/or DBP 90-109 mmHg; 24-h SBP=130- mmHg and/or 24-h DBP=80)
- Internet access and computer/smartphone compatible with actensio
- Able to complete data collection and intervention
- Ability to speak and read German
- Antihypertensive medication (prescribed by a doctor) that has been stable over the last 3 months (i.e. not changed) or no antihypertensive medication
- Possession of a blood pressure monitor
- Patients are able to participate fully in the clinical trial and comply with the requirements for participation
- Taking = 4 different classes of blood pressure medication
- Practice SBP = 180 and/or DBP = 110
- Life expectancy < 12 months
- Cardiovascular event within the last 6 months (e.g. stroke, heart attack, cerebral haemorrhage)
- Cancer diagnosis in the past 5 years or acute treatment with chemotherapy/immonosuppressants
- Current or planned pregnancy during the clinical trial; breastfeeding women
- cognitive impairment
- Participation in another clinical drug trial or medical device trial
- current or recent (within the last six months) participation in a lifestyle intervention programme (e.g. sports or diet programme)
- Employees of mementor or another institution involved in the conduct/organisation/coordination/financing of the clinical trial
- Relatives or life partners who have already participated in this clinical trial
- Previous use of actensio
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method